Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Some research reports alopecia as a potential adverse effect, with significantly higher rates observed with tirzepatide vs placebo (relative risk, 5.67
Some systematic reviews and meta-analyses have suggested potential benefits for glycaemic control and modest weight reduction
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for three primary indications: type 2 diabetes mellitus, chronic weight management, and cardiovascular risk reduction in adults with obesity/overweight and established cardiovascular disease
No, there is not yet an official standard maintenance dose because retatrutide remains under investigation
US$ 29.53
US$ 23.75
US$ 20.61
US$ 22.53
US$ 23.20
US$ 28.65
US$ 21.63
US$ 22.15
